Document is current
Any future updates will be listed below
-
Authors
Takeuchi, Tomonori https://orcid.org/0000-0002-9981-4260
Tamura, Makoto https://orcid.org/0000-0001-7034-8094
Tse, Dorothy https://orcid.org/0000-0003-2263-8139
Kajii, Yasushi
Fernández, Guillén https://orcid.org/0000-0002-5522-0604
Morris, Richard G. M. https://orcid.org/0000-0001-8661-1520
-
Funding
Funding for this research was provided by:
Novo Nordisk Fonden (NNF17OC0026774)
Lundbeckfonden (DANDRITE-R248-2016-2518)
Danish National Research Foundation (DNRF133)
Mitsubishi Tanabe Pharma Corporation
Wellcome Trust (Advanced Investigator Grant)
European Research Council (NEUROSCHEMA – No 268800, NEUROSCHEMA – No 268800)
- License Information
-
More Information
Article History
Received: 12 October 2021
Accepted: 26 February 2022
First Online: 24 March 2022
Declarations
:
: All animal experimental procedures were compliant with the United Kingdom Home Office Animal Procedures Act (1986) conducted under a Project Licence (PPL 60/4566).
: Not applicable.
: Makoto Tamura is an employee of Mitsubishi Tanabe Pharma Corporation. Yashushi Kajii was an employee of Mitsubishi Tanabe Pharma Corporation and is an employee of Takeda Pharmaceutical Company.
